ADVANCED R&D CAPABILITIES

With Global manufacturing efficiencies

Background Image

R&D

Mundipharma’s R&D is led from research centres in Singapore, USA, UK, Germany, China and Japan. We carry out pre-clinical research, pharmaceutical development, clinical development, drug safety, regulatory affairs and scientific support of new treatments.

rnd-icon-1

R&D is mainly conducted research centers in the US, UK and Germany, dedicated to developing only the most effective and innovative medications.

rnd-icon-2

Includes pre-clinical research, pharmaceutical and clinical development, drug safety, regulatory affairs and scientific support of new therapeutic products.

Mundipharma is constantly on the lookout for substances that offer better therapeutic options for patients, which will not only help treat their conditions but will also improve their quality of life. Mundipharma is also dedicated to developing products using only high ethical standards. Our products are the result of a dynamic relationship with our partners. As such, Mundipharma produces drugs that meet the needs of both doctors and patients.

Manufacturing

Our Technical Operations team oversees Manufacturing, Supply Chain, Quality and Technical Services support across an independent network of associated companies, joint ventures and supply chain partners.

Mundipharma leverages a network of world-class manufacturing facilities and product supply activities in the United States, Europe, Canada, Asia, Middle East, Africa, Latin America, Australia, and New Zealand. The network has nine internal manufacturing/supply locations and benefits from vertical integration.

↓